Mark Butler has worked in drug discovery since 1994 with a focus on natural products and has extensive experience in preclinical research, drug development, group and project management, intellectual property and workplace safety.
Current research interests include the discovery and development of new antibacterial and antifungal drug leads to clinical candidates and mode of action studies using chemical biology and metabolomic techniques.
Experience
2009–present
Senior Research Fellow Grade 2, Institute for Molecular Bioscience, The University of Queensland
2002–2009
Director Natural Product Chemistry, MerLion Pharmaceuticals Pte Ltd (Singapore)
1999–2002
Research Leader, Centre for Natural Product Research (Singapore)
1994–1999
Research Fellow, Queensland Pharmaceutical Research Institute, Griffith University
1992–1994
Postdoctoral Research Associate, Cancer Research Institute, Arizona State University (USA)